載入...
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.
Prophylactic treatment with fluoroquinolones of patients with profound neutropenia has been found to be useful for preventing gram-negative bacteremia and has become a standard preventive-therapy strategy in many cancer centers, but the development of bacterial resistance is a cause of concern. Duri...
Na minha lista:
| 發表在: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology (ASM)
1994
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284525/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8031031/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.4.681 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|